Skip to main content
Imagin Medical Inc. logo

Imagin Medical Inc. — Investor Relations & Filings

Ticker · IME ISIN · CA45250L1058 LEI · 549300RE833PUHZ5FG16 CSE Manufacturing
Open in API
Filings indexed 84 across all filing types
Latest filing 2024-01-26 Capital/Financing Update
Country CA Canada
Listing CSE IME

About Imagin Medical Inc.

https://imaginmedical.com/

Imagin Medical Inc. is a medical technology company focused on advancing surgical imaging and therapeutic solutions within urologic oncology. The company develops medical devices designed to enhance the visualization and treatment of cancer during minimally invasive procedures, primarily addressing bladder and prostate cancers. Its product portfolio includes the i/Blue™ Imaging System, which utilizes advanced technology to detect bladder cancer and visualize the surgical field, aiming to improve detection accuracy and reduce recurrence. Furthermore, Imagin is developing the enCAGE Coil™ Precision Ablation System, a specialized therapeutic device intended for the focal ablation treatment of prostate cancer. The company aims to provide physicians with tools for clear, accurate visualization and precise surgical intervention.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a company announcement providing updates on product development and financial status, including capital needs and management changes. It mentions fundraising efforts, postponement of activities due to capital constraints, and a CFO departure. There are no financial statements, detailed financial data, or comprehensive report content. The document is relatively short (2797 characters) and serves as a corporate update rather than a formal financial report or filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It also does not qualify as a Regulatory Filing since it is a substantive update rather than a certification or compliance document. The content aligns best with a Capital/Financing Update (CAP) as it focuses on the company's capital situation and fundraising efforts.
2024-01-26 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a short announcement about Imagin Medical completing an $80,000 financing transaction involving a note and share purchase warrants. It describes the financing details and intended use of proceeds but does not contain financial statements, detailed financial analysis, or regulatory certifications. The document length is 1798 characters, which is quite short and consistent with a financing update rather than a full report. There is no indication that this is a full annual or interim report, audit report, or earnings release. The content clearly focuses on a capital raising event. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2023-11-21 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution,' which is a regulatory filing related to securities distribution in Canada. It includes detailed information about the issuer, underwriter, and distribution specifics. The form is a standard regulatory disclosure rather than a financial report, earnings release, or management discussion. It does not contain financial statements or management analysis but serves as a compliance report for exempt distributions. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory documents that do not fit other specific categories.
2023-11-15 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Imagin Medical Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2023. The document is a certification letter, not the interim report itself, and it explicitly states it is a certificate under National Instrument 52-109. The document length is short (2990 characters) and it contains no actual financial data or analysis, only the certification statement. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself.
2023-05-24 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. It is a certification by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2023. The document does not contain the actual interim financial statements or substantive financial data but is a certification letter confirming the accuracy and completeness of the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the interim report itself. The document length is short (2996 characters), and it is clearly a certification rather than the full interim report.
2023-05-24 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion & Analysis' (MD&A) for the six months ended March 31, 2023, which is a detailed explanation of the company's financial results, business trends, and outlook for a period shorter than a full fiscal year. It references the condensed interim consolidated financial statements for the same period, indicating it is an interim report. The document is substantive, about 15,000 characters long, and contains detailed business descriptions, acquisitions, product information, and strategic plans. It is not merely an announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-05-24 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.